메뉴 건너뛰기




Volumn 13, Issue 4, 2012, Pages 4831-4838

Curcumin enhances cytotoxic effects of bortezomib in human multiple myeloma H929 cells: Potential roles of NF-κB/JNK

Author keywords

Curcumin; JNK; Multiple myeloma; NF B; PS 341

Indexed keywords

BORTEZOMIB; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRAZINE DERIVATIVE; RELA PROTEIN, HUMAN;

EID: 84860147556     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13044831     Document Type: Article
Times cited : (36)

References (19)
  • 2
    • 2642551603 scopus 로고    scopus 로고
    • Development of the proteasome inhibitor Velcade (Bortezomib)
    • Adams, J.; Kauffman, M. Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Invest. 2004, 22, 304-311.
    • (2004) Cancer Invest , vol.22 , pp. 304-311
    • Adams, J.1    Kauffman, M.2
  • 3
    • 0036240701 scopus 로고    scopus 로고
    • The proteasome: A novel target for cancer chemotherapy
    • Almond, J.B.; Cohen, G.M. The proteasome: A novel target for cancer chemotherapy. Leukemia 2002, 16, 433-443.
    • (2002) Leukemia , vol.16 , pp. 433-443
    • Almond, J.B.1    Cohen, G.M.2
  • 4
    • 0036690648 scopus 로고    scopus 로고
    • PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis
    • Ling, Y.H.; Liebes, L.; Ng, B.; Buckley, M.; Elliott, P.J.; Adams, J.; Jiang, J.D.; Muggia, F.M.; Perez-Soler, R. PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis. Mol. Cancer Ther. 2002, 1, 841-849.
    • (2002) Mol. Cancer Ther , vol.1 , pp. 841-849
    • Ling, Y.H.1    Liebes, L.2    Ng, B.3    Buckley, M.4    Elliott, P.J.5    Adams, J.6    Jiang, J.D.7    Muggia, F.M.8    Perez-Soler, R.9
  • 5
    • 0242468166 scopus 로고    scopus 로고
    • Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process
    • Dai, Y.; Rahmani, M.; Grant, S. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process. Oncogene 2003, 22, 7108-7122.
    • (2003) Oncogene , vol.22 , pp. 7108-7122
    • Dai, Y.1    Rahmani, M.2    Grant, S.3
  • 6
    • 70450227260 scopus 로고    scopus 로고
    • Proteasome inhibitors in the treatment of multiple myeloma
    • Shah, J.J.; Orlowski, R.Z. Proteasome inhibitors in the treatment of multiple myeloma. Leukemia 2009, 23, 1964-1979.
    • (2009) Leukemia , vol.23 , pp. 1964-1979
    • Shah, J.J.1    Orlowski, R.Z.2
  • 7
    • 0038473927 scopus 로고    scopus 로고
    • Flavopiridol in untreated or relapsed mantle-cell lymphoma: Results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group
    • Kouroukis, C.T.; Belch, A.; Crump, M.; Eisenhauer, E.; Gascoyne, R.D.; Meyer, R.; Lohmann, R.; Lopez, P.; Powers, J.; Turner, R., et al. Flavopiridol in untreated or relapsed mantle-cell lymphoma: Results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 2003, 21, 1740-1745.
    • (2003) J. Clin. Oncol , vol.21 , pp. 1740-1745
    • Kouroukis, C.T.1    Belch, A.2    Crump, M.3    Eisenhauer, E.4    Gascoyne, R.D.5    Meyer, R.6    Lohmann, R.7    Lopez, P.8    Powers, J.9    Turner, R.10
  • 8
    • 80053196640 scopus 로고    scopus 로고
    • Combining proteasome with cell cycle inhibitors: A dual attack potentially applicable to multiple hematopoietic malignancies
    • Holkova, B.; Grant, S. Combining proteasome with cell cycle inhibitors: A dual attack potentially applicable to multiple hematopoietic malignancies. Expert Rev. Hematol. 2011, 4, 483-486.
    • (2011) Expert Rev. Hematol , vol.4 , pp. 483-486
    • Holkova, B.1    Grant, S.2
  • 9
    • 0028867742 scopus 로고
    • Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane)
    • Singh, S.; Aggarwal, B.B. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 1995, 270, 24995-25000.
    • (1995) J. Biol. Chem , vol.270 , pp. 24995-25000
    • Singh, S.1    Aggarwal, B.B.2
  • 11
    • 84859047406 scopus 로고    scopus 로고
    • BDMC33, a curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: Role of inhibition in NF-κB and MAPK signaling pathways
    • Lee, K.H.; Chow, Y.L.; Sharmili, V.; Abas, F.; Alitheen, N.B.M.; Shaari, K.; Israf, D.A.; Lajis, N.H.; Syahida, A. BDMC33, a curcumin derivative suppresses inflammatory responses in macrophage-like cellular system: Role of inhibition in NF-κB and MAPK signaling pathways. Int. J. Mol. Sci. 2012, 13, 2985-3008.
    • (2012) Int. J. Mol. Sci , vol.13 , pp. 2985-3008
    • Lee, K.H.1    Chow, Y.L.2    Sharmili, V.3    Abas, F.4    Alitheen, N.B.M.5    Shaari, K.6    Israf, D.A.7    Lajis, N.H.8    Syahida, A.9
  • 12
    • 36849018017 scopus 로고    scopus 로고
    • Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R
    • Patel, B.B.; Sengupta, R.; Qazi, S.; Vachhani, H.; Yu, Y.; Rishi, A.K.; Majumdar, A.P. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int. J. Cancer 2008, 122, 267-273.
    • (2008) Int. J. Cancer , vol.122 , pp. 267-273
    • Patel, B.B.1    Sengupta, R.2    Qazi, S.3    Vachhani, H.4    Yu, Y.5    Rishi, A.K.6    Majumdar, A.P.7
  • 13
    • 27144468987 scopus 로고    scopus 로고
    • Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice
    • Aggarwal, B.B.; Shishodia, S.; Takada, Y.; Banerjee, S.; Newman, R.A.; Bueso-Ramos, C.E.; Price, J.E. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin. Cancer Res. 2005, 11, 7490-7498.
    • (2005) Clin. Cancer Res , vol.11 , pp. 7490-7498
    • Aggarwal, B.B.1    Shishodia, S.2    Takada, Y.3    Banerjee, S.4    Newman, R.A.5    Bueso-Ramos, C.E.6    Price, J.E.7
  • 14
    • 66449104640 scopus 로고    scopus 로고
    • Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model
    • Sung, B.; Kunnumakkara, A.B.; Sethi, G.; Anand, P.; Guha, S.; Aggarwal, B.B. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol. Cancer Ther. 2009, 8, 959-970.
    • (2009) Mol. Cancer Ther , vol.8 , pp. 959-970
    • Sung, B.1    Kunnumakkara, A.B.2    Sethi, G.3    Anand, P.4    Guha, S.5    Aggarwal, B.B.6
  • 15
    • 56349157010 scopus 로고    scopus 로고
    • Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells
    • Park, J.; Ayyappan, V.; Bae, E.K.; Lee, C.; Kim, B.S.; Kim, B.K.; Lee, Y.Y.; Ahn, K.S.; Yoon, S.S. Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells. Mol. Oncol. 2008, 2, 317-326.
    • (2008) Mol. Oncol , vol.2 , pp. 317-326
    • Park, J.1    Ayyappan, V.2    Bae, E.K.3    Lee, C.4    Kim, B.S.5    Kim, B.K.6    Lee, Y.Y.7    Ahn, K.S.8    Yoon, S.S.9
  • 16
    • 84862832998 scopus 로고    scopus 로고
    • Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism
    • Zhang, X.Y.; Bai, Q.X.; Huang, G.S.; Zhao, H.; Chen, J.J.; Yang, L.J. Effect of curcumin in combination with bortezomib on proliferation and apoptosis of human multiple myeloma cell line H929 and its mechanism. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011, 19, 684-688.
    • (2011) Zhongguo Shi Yan Xue Ye Xue Za Zhi , vol.19 , pp. 684-688
    • Zhang, X.Y.1    Bai, Q.X.2    Huang, G.S.3    Zhao, H.4    Chen, J.J.5    Yang, L.J.6
  • 17
    • 84855162753 scopus 로고    scopus 로고
    • Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs
    • Mujtaba, T.; Kanwar, J.; Wan, S.B.; Chan, T.H.; Dou, Q.P. Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs. Int. J. Mol. Med. 2012, 29, 102-106.
    • (2012) Int. J. Mol. Med , vol.29 , pp. 102-106
    • Mujtaba, T.1    Kanwar, J.2    Wan, S.B.3    Chan, T.H.4    Dou, Q.P.5
  • 18
    • 78650371990 scopus 로고    scopus 로고
    • MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
    • Liang, J.; Saad, Y.; Lei, T.; Wang, J.; Qi, D.; Yang, Q.; Kolattukudy, P.E.; Fu, M. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling. J. Exp. Med. 2010, 207, 2959-2973.
    • (2010) J. Exp. Med , vol.207 , pp. 2959-2973
    • Liang, J.1    Saad, Y.2    Lei, T.3    Wang, J.4    Qi, D.5    Yang, Q.6    Kolattukudy, P.E.7    Fu, M.8
  • 19
    • 79955665002 scopus 로고    scopus 로고
    • Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-κB and JNK/p38 MAPK activation pathways
    • doi:10.1186/1423-0127-18-28
    • Hsieh, I.N.; Chang, A.S.; Teng, C.M.; Chen, C.C.; Yang, C.R. Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-κB and JNK/p38 MAPK activation pathways. J. Biomed. Sci. 2011, 18, doi:10.1186/1423-0127-18-28.
    • (2011) J. Biomed. Sci , pp. 18
    • Hsieh, I.N.1    Chang, A.S.2    Teng, C.M.3    Chen, C.C.4    Yang, C.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.